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tRNADuring mRNA decoding at the ribosome, deviations from stringent codon identity, or
‘‘mistranslation,’’ are generally deleterious and infrequent. Observations of organisms that decode
some codons ambiguously, and the discovery of a compensatory increase in mistranslation fre-
quency to combat environmental stress have changed the way we view ‘‘errors’’ in decoding.
Modern tools for the study of the frequency and phenotypic effects of mistranslation can provide
quantitative and sensitive measurements of decoding errors that were previously inaccessible.
Mistranslation with non-protein amino acids, in particular, is an enticing prospect for new drug
therapies and the study of molecular evolution.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.The ﬂow of information from the genetic code to the protein
code is an imperfect process. Errors in transcribing messenger
RNA from the genomic template and in decoding mRNA at the ribo-
some typically occur at low levels, yielding protein populations
with only minor sequence variability [1]. One of the primary effec-
tors of this high degree of quality control is the aminoacyl-tRNA
synthetase family of enzymes, which pair amino acids with their
appropriate tRNAs to form aminoacyl-tRNAs for use as substrates
in peptide synthesis by the ribosome [2]. Errors in aminoacyl-tRNA
synthetase function can result in the production of mispaired ami-
noacyl-tRNAs and erroneous insertion of amino acids at codons in
a manner not deﬁned by the genetic code, a phenomenon called
‘‘mistranslation’’ [3,4]. These deviations from the genetic code
can be associated with a loss of protein structural and functional
integrity as well as phenotypic defects and disease [5]. Recent
work has demonstrated that mistranslation may beneﬁt the cell
in certain circumstances (see [6] and references therein) and that
some organisms have selected for a higher degree of mistranslation
than others [7–10]. Moreover, conditional cellular stress presents
unique challenges to accurate aminoacyl-tRNA synthesis [11,12],
underscoring the emerging view of quality control as a dynamicprocess dependent on the cellular microenvironment and other
evolutionary pressures.
1. Introduction
Central to all life is the ﬂow of information from a genetic code
to an RNA and protein code [13]. Transcription of genetic informa-
tion into an RNA code and translation of that RNA code into an
amino acid sequence are processes that have long been thought
to tolerate few errors. An inaccurately transcribed DNA base can
result in an mRNA codon with different identity, and inaccurate
decoding of mRNA codons at the ribosome can result in inappropri-
ate amino acid insertion in a nascent peptide. Such errors in infor-
mation ﬂow can result in truncated and/or misfolded proteins,
proteins with neutral or deleterious substitutions at critical resi-
dues [14], and an overall loss in protein function at the molecular
and cellular levels [15].
Maintaining accurate ribosomal protein synthesis, in particular,
is critical to all life. Atypical of most enzymatic processes in the
cell, protein synthesis requires permissivity in the enzymatic
binding site, allowing for dozens of substrate aminoacyl-tRNAs
(aa-tRNAs) bearing the full complement of proteinogenic amino
acids to be incorporated into proteins. The nature of genetically
encoded amino acid sequences necessitates speciﬁcity at the
ribosome for canonical aa-tRNAs, such that for each codon, only
an aa-tRNA bearing the genetically encoded amino acid can bind
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ribosomal quality control mechanisms that rely on codon-antico-
don interactions [16,17] and discrimination against certain types
of non-protein amino acids (NPAs), which can be attenuated with
ribosomal mutations [18,19]. However, no such quality control
mechanism exists in the ribosome to exclude aa-tRNAs formed
from the linkage of a standard proteinogenic amino acid to a
non-cognate tRNA. In such a case, codon-anticodon interactions
that pass the quality control steps at the ribosome will drive pro-
tein synthesis forward. Ribosomal quality control may instead act
retrospectively, by increasing the frequency of errors in decoding
a given mRNA, facilitating premature release of mis-synthesized
peptides from the ribosome [20–22]. The phenomenon of amino
acid insertion at a codon that codes for a different amino acid is
termed ‘‘mistranslation,’’ and until recently has been thought to
reﬂect a minor and infrequent imperfection in the protein synthe-
sis machinery.
Mistranslation is typically limited to one erroneously inserted
amino acid per 103–104 translated codons [1]. Many mutations
and environmental conditions are known to elevate this error rate
beyond tolerable limits [5,23]. Recent studies have uncovered dif-
ferences between organisms in the requirement for quality control
in protein synthesis [7,10,24], suggesting that perfect decoding
may not be inherently ideal. Mistranslation of the genetic code in
response to cellular stress has been shown in some cases to serve
as a clear beneﬁt for the cell [23]. It is a misinterpretation of an
ambiguous term to equate ‘‘mistranslation’’ with ‘‘mistakes’’ in
all cases, as variability in decoding is sometimes evolutionarily
conserved and favorable [25,26]. In this review, we highlight chal-
lenges and recent advances in the way variability in decoding is
measured, address environmental and evolutionary determinants
of quality control in protein synthesis, and reevaluate the way
we view ‘‘errors’’ in translational decoding to more accurately
reﬂect the range of positive and negative effects that mistransla-
tion has on the cell.
2. Mass spectrometry as a tool for measuring protein
mistranslation
One of the greatest challenges in studying mistranslation is
quantitative measurement of amino acid substitutions, particularly
low-frequency events. Traditionally, measurement of mistransla-
tion has been carried out indirectly, by quantifying amino acid sub-
stitutions in exogenously expressed proteins, such as b-lactamase,
green ﬂuorescent protein, and others [27–29]. In these analyses,
critical residues of the reporter protein of interest are mutated
such that mistranslation of the codon of interest will restore the
protein sequence and/or change the protein’s functionality.
Reporter protein activity is quantiﬁed under various conditions,
and residue-speciﬁc mistranslation is inferred as a result.
There are several drawbacks to this kind of analysis. Replication
of exogenous genetic material and expression of a protein reporter
alter the metabolic proﬁle of the host organism, potentially con-
founding studies of natural variation in decoding [30]. Moreover,
biologically relevant low-frequency amino acid substitution events
may be undetectable or underrepresented in these systems, and
this type of analysis erroneously assumes that mistranslated pep-
tides have comparable half-lives to the accurately translated form
[31]. Perhaps most importantly, these techniques are used for
detection of speciﬁc amino acid substitutions at a chosen codon,
limiting the scope of study to a case-by-case analysis in a speciﬁc
primary sequence context. Given the anticipated variables that
determine mistranslation, another drawback of these types of anal-
yses is the assumption that they reﬂect mistranslation of all rele-
vant codons. As a result, it has long been difﬁcult to properly and
sensitively quantify typical amino acid substitution rates on aper-codon basis with multiple amino acid residues, and to address
global rates and effects of mistranslation.
More recently, sophistication in analytical mass spectrometry
has provided the means for direct, highly sensitive measurement
of mistranslation at each codon with multiple amino acids. In par-
ticular, liquid chromatography–electrospray ionization tandem
mass spectrometry (LC–ESI-MS/MS) with or without the use of
multiple reaction monitoring (MRM) mode is the new technique
of choice [32–35]. Proteolytically digested protein samples are sep-
arated by liquid chromatography and the eluent peptides are ion-
ized via an electrospray source. In the case of a linear triple
quadrupole setup, a target peptide of interest is mass-selected on
the ﬁrst quadrupole and is fragmented in a collision chamber.
Resulting fragment ions are mass analyzed on a second quadru-
pole. MRM mode entails analysis of a selected few fragment ions
on the second quadrupole, which contrasts full scan MS/MS, in
which all resulting fragment ions are quantiﬁed. MRM yields
greater sensitivity than full scan MS/MS, allowing for greater
detection of low-frequency mistranslation. Alternatively, fragment
ions may be mass analyzed with an orbitrap type mass analyzer,
which also offers a high resolution and sensitivity. These tech-
niques allow for measurement of normal levels of mistranslation
at each codon in a global fashion, and have provided the tools to
examine perturbations from the norm caused by changes in the
cellular environment.
Industrial protein manufacturers have largely pioneered this
analysis as a method to test the quality and homogeneity of their
protein products. A common method of large-scale human
antibody production involves exogenous expression in Chinese
hamster ovary (CHO) cells [36]. Mammalian protein production
is convenient, as post-translational modiﬁcations are typically sim-
ilar to the human protein products, and alternative synthetic
chemistry methods are expensive and inefﬁcient by comparison.
The primary downside is that organismal protein synthesis is
subject to typically low-level variability in decoding, resulting in
a statistical population of protein products with heterogeneity in
the primary sequence [33–35,37].
Because variability in decoding can increase in certain environ-
mental contexts, the exact growth media must be carefully
controlled and quality control in protein products must be moni-
tored frequently. Under conditions of tyrosine (Tyr) limitation, it
was recently discovered that CHO cells suffer growth defects and
accumulate phenylalanine (Phe) at Tyr codons in heterologously-
produced monoclonal antibodies at frequencies as high as 0.7%, a
value much greater than that quoted for typical mistranslation
(0.01%) [12,34]. Upon further examination, it was discovered that
tyrosyl-tRNA synthetase (CHO TyrRS), the enzyme responsible for
producing Tyr-tRNATyr in the CHO cytoplasm, exhibits inherently
poor discrimination against Phe, which is similar in structure to
cognate Tyr [12]. As a result, CHO TyrRS produces Phe-tRNATyr,
which, when used as a substrate for protein synthesis at the ribo-
some, results in Phe misincorporated at Tyr codons. By increasing
the bioavailability of tyrosine to CHO cells, this mistranslation is
greatly decreased [38], indicating that amino acid starvation and
poor discrimination by CHO TyrRS were responsible for mistransla-
tion-dependent heterogeneity in the protein product.
Bacterial tyrosyl-tRNA synthetase (TyrRS) is highly speciﬁc for
Tyr over Phe, even under Tyr limitation [39], so the poor discrimi-
nation exhibited by this higher eukaryote is surprising. This may be
of particular interest to the study of diseases such as phenylketon-
uria, in which the ratio of Phe to Tyr is similarly affected [40], and
results in human neurological defects similar to many diseases
involving mutated aaRSs [5,41]. Treatment of phenylketonurics
includes dietary restriction of Phe and supplementation with Tyr
such that normal intracellular Phe/Tyr ratios are maintained in
the absence of adequate phenylalanine hydroxylase activity. In a
A. Moghal et al. / FEBS Letters 588 (2014) 4305–4310 4307broader sense, the absence of stringent quality control to limit mis-
translation at Tyr codons in CHO cells is further evidence that the
evolutionary determinants for accuracy in protein synthesis are
apparently varied. Many speciﬁc and conditional mistranslation
events are known [11,12,23,26,35,37,42,43], and we are just
beginning to scratch the surface of which types of amino acid sub-
stitutions occur in which organisms, under what conditions, by
what mechanisms, and to what effect.
3. Evolutionary surprises in decoding dynamics
Most organisms contain at least 20 aminoacyl-tRNA syntheta-
ses (aaRSs) [44], which pair tRNAs with each proteinogenic amino
acid to produce aminoacyl-tRNAs (aa-tRNAs), the substrates for
ribosomal protein synthesis (Fig. 1). For the ribosome to perform
its function accurately, aaRSs must bind only their appropriate,
or ‘‘cognate,’’ amino acids and tRNAs, lest misacylated aa-tRNAs
be synthesized. aaRSs accomplish this discriminatory task primar-
ily by exclusion of incorrect or ‘‘non-cognate’’ amino acids and
tRNAs. Non-cognate amino acids and tRNAs that vary in size,
shape, charge, and/or hydrophobicity will be excluded from
respective binding pockets. Because tRNAs differ from one another
by a larger surface area and more discriminatory functional groups
than amino acids, tRNA selection is typically the lesser challenge
[45–47]. aa-tRNA synthesis is a two-step process [2]. In the ﬁrst
step, aaRSs catalyze the synthesis of activated amino acids, called
aminoacyl-adenylates (aa-AMPs) using the chemical energy stored
in ATP. These aa-AMPs are the substrates for the second catalytic
step, whereby the aminoacyl moiety is transferred to the 30-OH
of a tRNA bound to the aaRS. In the event that a non-cognate amino
acid is not excluded in the binding pocket, it may be activated,
forming an aa-AMP. Some aaRSs prevent subsequent aminoacyl-
tRNA formation by hydrolyzing misactivated aa-AMP, a processed
termed ‘‘pre-transfer editing’’ [48], which is tRNA-dependent in
some cases [49]. If this does not occur, a mispaired aa-tRNA may
be synthesized and released, providing a substrate for mistransla-
tion at the ribosome. Approximately half of the aaRSs bear a cata-
lytic domain independent of the canonical aa-tRNA synthetic site.
This separate ‘‘editing’’ domain serves to hydrolyze misacylated
tRNAs. Termed ‘‘post-transfer editing,’’ aa-tRNA hydrolysis may
be performed by an aaRS in cis, prior to aa-tRNA release, or upon
re-binding a misacylated aa-tRNA species in trans [50]. In addition,
freestanding post-transfer editing domain homologues serve as an
additional layer of quality control [51–54]. Post-transfer editing
limits the population of mischarged tRNA species that may threa-
ten accurate decoding at the ribosome. The types of aaRS editing
have been reviewed extensively elsewhere [3].
The standard genetically encoded proteinogenic amino acids
are not the only threats to quality control in aa-tRNA synthesis.+ AMP
ATP
+
PPi
Amino Acid 
Acvaon
Pre-Transfer
Eding
Fig. 1. Aminoacyl-tRNA synthesis and quality control mechanisms. aa-tRNA synthesis
formation. An aminoacyl-adenylate formed by the activation of a non-cognate amino ac
aaRS. Misactivated amino acids that escape pre-transfer editing may be acylated to tRNA,
may be hydrolyzed, releasing the amino acid and tRNA.Additional ‘‘non-protein’’ amino acids (NPAs) with similar physio-
chemical properties to proteinogenic amino acids must be discrim-
inated against by relevant aaRSs. In the past year, post-transfer
editing has been implicated to a greater degree as a mechanism
by which the cell is protected from NPAs generated under condi-
tions of stress. In Escherichia coli, phenylalanyl-tRNA synthetase
(PheRS) bears a post-transfer editing domain, the activity of which
is dispensable under normal conditions. The near-cognate protein-
ogenic amino acid Tyr is not misacylated to tRNAPhe to a degree
that threatens cellular viability, and PheRS editing-deﬁcient
mutants survive in the presence of Tyr. Under conditions that favor
the formation of reactive oxygen species, however, PheRS editing is
critical for cellular survival. It was discovered that the NPA meta-
tyrosine (m-Tyr) accumulates under oxidative stress, is charged
appreciably to tRNAPhe, and is translated at Phe codons [11]. Taken
together, this suggests that post-transfer editing by E. coli PheRS,
while not necessary under normal conditions, is critical to protect
the cell from cytotoxic mistranslation with a NPA under conditions
of oxidative stress. In the yeast Saccharomyces cerevisiae, cytosolic
PheRS similarly bears post-transfer editing domain activity,
whereas mitochondrial PheRS relies instead on high discrimination
in the activation step to maintain quality control (Fig. 2). Muta-
tional attenuation of mitochondrial PheRS selective discrimination
for Phe/Tyr from 12000:1 to 700:1 limits growth on respiratory
media and prevents mitochondrial biogenesis [55]. Ablation of
cytoplasmic PheRS editing activity has no effect on Phe/Tyr
selectivity, and mutants maintain viability but become sensitive
to elevated Phe:Tyr ratios. The S. cerevisiae post-transfer editing
mutant also exhibits a phenotypic loss of viability under conditions
of oxidative stress (unpublished data). This suggests that post-
transfer editing by S. cerevisiae cytosolic PheRS and E. coli PheRS
may be conserved in part to protect the cell from mistranslation
of Phe codons with the NPA m-Tyr that accumulates under condi-
tions of oxidative stress.
Similarly, post-transfer editing by E. coli leucyl-tRNA synthetase
(LeuRS) has been shown to typically be dispensable, and the near-
cognate proteinogenic amino acid isoleucine (Ile) is not an efﬁcient
substrate for LeuRS [56]. Under conditions that favor the accumu-
lation of certain near-cognate proteinogenic amino acids and NPAs,
LeuRS post-transfer editing is critical [57,58]. Norvaline is an efﬁ-
cient substrate for LeuRS and may represent a signiﬁcant threat
to quality control at leucine codons under conditions of oxygen
limitation, which induce intracellular norvaline accumulation
[56,57]. Again, it seems that evolution may favor the conservation
of post-transfer editing in part to protect the cell against cytotoxic
mistranslation of the genetic code with NPAs, some of which are
only biologically relevant threats to the cell under stress
conditions. More examples of this phenomenon are likely to arise
in the near future, and current models will be reﬁned as broadAMP
+
Aminoacyl
Transfer
Post-Transfer
Eding
is a two-step process, with checkpoints at each step to ensure proper product
id may be hydrolyzed by pre-transfer editing mechanisms in the active site of the
forming aa-tRNA. If an aaRS bears a post-transfer editing domain, mispaired aa-tRNA
COO-H3N + COO
-H3N +
OH
Phenylalanine meta-Tyrosine
COO-H3N +
Leucine
COO-H3N +
Norvaline
PheRS
LeuRS
Cognate NPA Noncognate
Fig. 2. Non-protein amino acids as a threat to quality control in aminoacyl-tRNA
synthesis. NPAs that pose a threat to translational ﬁdelity bear similar physio-
chemical and structural features compared to cognate amino acids. E. coli PheRS
post-transfer editing activity prevents release of tRNAPhe charged with the NPA
m-Tyr, which differs from cognate Phe by a single oxygen atom [11]. E. coli LeuRS
post-transfer editing activity prevents release of tRNALeu charged with norvaline,
which differs from cognate Leu by a methylene group [56,58].
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uncover additional mistranslated non-cognates and we begin to
better understand the role of NPAs.
4. Deﬁningmistranslation, deviation from the norm, and effects
on the cell
In recent years, mistranslation has been viewed through a
different lens than in previous decades. This is due in part to the
observation of high degrees of mistranslation tolerated in certain
species and the discovery of conditional increases in the frequency
of mistranslation that mitigate environmental stress. Under condi-
tions of oxidative stress, non-methionyl tRNAs can be methionylat-
ed by methionyl-tRNA synthetase from E. coli [25], yeast [26], and
mammals [23]. Because methionine may spontaneously react with
reactive oxygen species (ROS) that are formed under oxidative
stress, methionine residues mistranslated at non-methionyl
codons may serve as ROS ‘‘sinks,’’ to be later safely reduced by
methionine sulfoxide reductases [59]. Such ‘‘adaptive translation’’Low-Frequency Mistranslation H
Fig. 3. Mistranslation and the statistical proteome. Represented here are various copies
systems. Amino acids inserted at appropriate codons are shown as blue. Inappropriatel
infrequent, resulting in protein populations with minor variability. In organisms that
stringent quality control [12,23,25,26], protein populations become more diverse in th
folding and binding properties, resulting in phenotypic diversity in the host organism. Ex
the molecular and cellular levels.is reviewed extensively in [6]. In one notable example the Candida
albicans CUG codon is inherently decoded in an ambiguous man-
ner, and the resulting proteomic and phenotypic diversity [9]
may make this opportunistic pathogen a ‘‘moving target’’ for the
host’s adaptive immune system [8].
Taken together, these examples illustrate the substantial
difﬁculty in simply deﬁning mistranslation, given the degree to
which some organisms tolerate or beneﬁt from codon ambiguity.
‘‘Mistranslation,’’ ‘‘errors’’ in protein synthesis, and ‘‘accuracy’’ in
translation are terms that implicitly assign a negative value to
deviations from stringent deﬁnitions of codon identity. Moreover,
consideration of the basal level of mistranslation on a per-protein
level is too limited in scope, as the full complement of proteins in
the cell has, by the statistical nature of misincorporation, a wide
range of primary sequences (Fig. 3). This ‘‘statistical protein’’ model
implies a frequency of misincorporation at every codon, such that
any given amino acid has a certain probability of translation at a
given codon. Quality control mechanisms inherent to the transla-
tion machinery limit these errors, but the system is imperfect
and dynamic; perturbations in amino acid pools [11,12], modiﬁca-
tion in the copy number or modiﬁcation status of tRNAs [60–62],
and aaRSs [29], can all change the frequency of translated amino
acids at a given codon. Expanding this picture to include every
newly synthesized protein in new growth conditions and retaining
the non-degraded protein from all previous growth conditions fur-
ther complicates the picture of the mistranslation frequencies of
protein sequences in the cell.
Because the primary sequence of a protein determines its fold
and function, variation in the primary sequence can result in
‘‘neomorphic’’ proteins, which bear new and different functions
in binding and catalysis than those of the parent protein. Variations
in protein sequence due to genetic mutation are the basis of evolu-
tion, resulting in heritable allelic diversity. Mutation is typically
deleterious or neutral at best, but occasionally reﬁnes or gives
new beneﬁcial function to a protein. These heritable mutant pro-
teins may grant the organism a selective advantage and thus the
new sequence becomes a feature of the species.
Mistranslation in a protein population instead results in non-
heritable diversity at the protein level. A population of proteins
with variability in their primary sequence may have varying
degrees of mistranslation with many different amino acids at manyigh-Frequency Mistranslation
of a single protein arising from translation in low- or high-frequency mistranslation
y inserted amino acids are represented as green and red. Typical mistranslation is
naturally mistranslate more frequently [7,10], or in conditions that promote less
eir primary sequences. Proteins arising from ‘‘statistical proteomes’’ have various
panded to include all proteins in a cell, the effects of mistranslation can be drastic at
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proteins. Proteins with neomorphic moonlighting functions impli-
cated in disease have been discussed elsewhere [63,64]. Under
normal conditions, the effects of low-frequency mistranslation
may be minimal. In conditions that increase the frequency of these
replacement events, drastically varied peptide sequences may
become a double-edged sword: whereas randomness in protein
populations may decrease the binding and catalytic function of a
protein population as a whole and can result in aggregation and
growth defects [5], individual proteins with neomorphic properties
may grant the cell access to new and beneﬁcial binding partners
and catalytic activities not derived from the genetically-encoded
primary sequence. The cost-beneﬁt calculus of protein quality con-
trol thus depends on environmental factors and the complement of
tools for combating the negative effects of mistranslation at the
disposal of the organism in question. Perhaps some NPAs condi-
tionally charged to tRNAs will be discovered to have a role that
beneﬁts, rather than harms the cell. Such a conditional increase
in the protein alphabet implies newmodes of binding and, depend-
ing on the chemical properties of the NPA, possibly unknown
modes of catalysis.
5. Outlooks
The fact of conditional mistranslation is no longer a surprise,
but the tools for deeper study of its possible signiﬁcance have been
lacking until recently. Greater analytical power afforded by sensi-
tive mass spectrometry and bioinformatic tools will soon make this
the technique of choice for the study of mistranslation. Mass
spectrometry can be used to directly detect and quantify low-level
mistranslation as well as identify, in a codon-speciﬁc manner, the
kinds of non-cognate amino acids translated, and under what
conditions. Particularly, knowledge of the role and prevalence of
mistranslation with NPAs will be expanded; additional NPAs may
be identiﬁed at multiple codons with multiple phenotypic effects.
A global picture of mistranslation in wild-type organisms from
multiple branches of the tree of life, under various conditions, will
provide a picture of evolutionarily conserved quality control
mechanisms and various degrees of permissive decoding. aaRSs
in particular are deeply conserved cellular factors, due to their cen-
tral role in translation, and it is expected that variation in aaRS
speciﬁcities between organisms may provide targets for therapeu-
tic and antibiotic treatment [65]. High throughput use of these
techniques may be used to identify and treat protein disease on a
per-patient basis. We may even see the design of synthetic NPAs
that target speciﬁc aaRSs under certain conditions, a prospect that
has many implications for cellular synthetic protein chemistry and
drug discovery. Translation of speciﬁc codons with NPAs has
already been used to introduce novel chemistry into cells, which
allows for new analytical techniques, protein-drug conjugation,
and novel protein interactions in vivo [66–69].
Recently, it was discovered that the NPA b-aminomethylalanine
(BMAA) is mistranslated at serine (Ser) codons in human tissue
[43]. Media supplementation with serine drastically reduces the
degree of this mistranslation, suggesting that non-cognate BMAA
competition with cognate Ser for seryl-tRNA synthetase may be
the source of the error in protein synthesis. Ingestion of BMAA is
associated with an increased risk for neurodegenerative disorders
such as amyotrophic lateral sclerosis, Alzheimer’s disease, and
Parkinsonism [70–72]. It is a tantalizing prospect to use dietary
supplementation with cognate amino acids as a treatment for
diseases such as these, as proteinogenic amino acids are cheap to
produce, are widely available over the counter, and are normal
humanmetabolites. It is conceivable that inducing speciﬁc changes
in amino acid pools, chemically modifying the selectivity of aaRSs,or designed NPA treatment may be used in various combinations to
combat many diseases with minimal deleterious effects on the
patient.
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